ETR Associates
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, ETR Associates sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
ETR Associates: 6 sponsored US clinical trials, 1 recruiting.
ETR Associates sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is HIV/AIDS and Infections, with 1 trials.
Upper-quartile sponsor footprint
ETR Associates sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
NCT06581536
PrEPTECH Phase 2 Study of a PrEP Telehealth Intervention
NCT04902820
Evaluation of the Trans Women Connected Mobile App for Changes in Sexual Health-related Behavior Among Transgender Women
NCT03897049
Evaluation of 3T, a Sex-Positive HIV/STI Mobile App Intervention for Young Black Men Ages 14-19 Attracted to Men
NCT04135443
A Healthy Relationships Program for Vulnerable Youth
NCT03736876
Rigorous Evaluation of High School FLASH
NCT04079608
What is open in the ETR Associates pipeline
1 recruiting of 6 indexed (17% open); 5 completed (83%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: HIV/AIDS and Infections (1 trial), 8 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
ETR Associates: open-pipeline peers nationwide
Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
ETR Associates sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this ETR Associates page
6 registered trials is a research-attention snapshot, not an endorsement of ETR Associates or any single study.
- 1 of ETR Associates's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- HIV/AIDS and Infections is the condition ETR Associates studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV/AIDS and Infections trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. ETR Associates pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.